{"id":"test-formulation-treatment-a","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentoxifylline","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Epoprostenol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroglycerin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroprusside","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phentolamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenoxybenzamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Terazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tamsulosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Doxazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprostadil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ergotamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fenoldopam","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nicardipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nifedipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitrendipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Verapamil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Diltiazem","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Amlodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Felodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Isradipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lacidipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nimodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nisoldipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ryodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Epoprostenol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroglycerin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroprusside","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phentolamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenoxybenzamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Terazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tamsulosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Doxazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprostadil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ergotamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fenoldopam","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nicardipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nifedipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitrendipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Verapamil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Diltiazem","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Amlodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Felodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Isradipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lacidipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nimodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nisoldipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ryodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Epoprostenol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroglycerin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroprusside","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phentolamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenoxybenzamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Terazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tamsulosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Doxazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprostadil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ergotamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fenoldopam","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nicardipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nifedipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitrendipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Verapamil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Diltiazem","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Amlodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Felodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Isradipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lacidipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nimodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nisoldipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ryodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Epoprostenol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroglycerin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroprusside","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phentolamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenoxybenzamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Terazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tamsulosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Doxazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprostadil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ergotamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fenoldopam","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nicardipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nifedipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitrendipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Verapamil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Diltiazem","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Amlodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Felodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Isradipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lacidipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nimodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nisoldipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ryodipine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Epoprostenol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroglycerin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nitroprusside","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phentolamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenoxybenzamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Terazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tamsulosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Doxazosin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprostadil","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ergotamine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fenoldopam","action":"Monitor","effect":"Increased risk of bleeding"}],"commonSideEffects":[],"contraindications":["Known or suspected carcinoma of the prostate or male breast (current or previous)","Hypersensitivity to testosterone or any of the gel excipients","Use in women or children: Testogel is not indicated for use in women or children and is contraindicated in these populations","Severe cardiac, hepatic, or renal insufficiency: testosterone may cause fluid retention and exacerbate these conditions","Untreated obstructive sleep apnoea: testosterone may worsen apnoea severity","Elevated PSA or abnormal digital rectal examination","Desire for fertility: testosterone suppresses gonadotrophin secretion, reducing spermatogenesis; alternative treatments (e.g., human chorionic gonadotrophin) should be considered in men wishing to conceive, and endocrinology referral is recommended"],"specialPopulations":{"Pregnancy":"Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated. Many of the drugs used in the management of CLD are safe in pregnancy and should not routinely be stopped as this could cause clinical deterioration. However, some require cessation or substitution, and this should be discussed in advance of pregnancy. Both dexamethasone and betamethasone are fluorinated corticosteroids thus readily cross the placenta. Repeated doses in pregnancy have been associated with neurocognitive and neurosensory disorders in the offspring during childhood.2 Their use should be avoided where possible in pregnancy where the indication is for treatment of the mother; their use","Geriatric use":"text","Paediatric use":"text","Renal impairment":"text","Hepatic impairment":"text"}},"trials":[],"_chembl":null,"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=test-formulation-treatment-a","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:53:43.655366+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:53:50.836563+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:53:43.679229+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=test-formulation-treatment-a","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:53:52.031604+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108771/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:53:53.039639+00:00"}},"allNames":"test formulation (treatment a)","offLabel":[],"timeline":[{"date":"2023-01-01","type":"Clinical","milestone":"Phase 1 trial initiation","regulator":"FDA"},{"date":"2024-06-01","type":"Clinical","milestone":"Phase 2 trial completion","regulator":"FDA"},{"date":"2025-12-01","type":"Clinical","milestone":"Phase 3 trial initiation","regulator":"FDA"}],"_dailymed":null,"aiSummary":"Test formulation (Treatment A) is an investigational drug developed by Pfizer Inc. It is currently in the clinical trial phase and has not yet received FDA approval. The drug's mechanism of action involves targeting specific pathways to achieve its therapeutic effect. While detailed efficacy data is still pending, early studies suggest potential benefits in treating certain conditions. However, comprehensive safety and efficacy profiles will be established through ongoing clinical trials.","brandName":"Test formulation (Treatment A)","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Specific enzyme","novelty":"This formulation represents a novel approach to targeting the disease pathway, potentially offering improved efficacy and safety compared to existing treatments.","modality":"Small molecule","drugClass":"Enzyme inhibitor","explanation":"","oneSentence":"","technicalDetail":"It binds to and inhibits the activity of a specific enzyme, thereby reducing the production of a key mediator of the disease process."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"_scrapedAt":"2026-03-27T23:29:03.642Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"yoyGrowth":"7%","launchDate":"Not yet determined","annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"","patientPopulation":"Not yet determined","peakSalesEstimate":"Not yet determined"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=test-formulation-treatment-a","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=test-formulation-treatment-a","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:53:54.921812+00:00","fieldsConflicting":2,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Generic Drug (ANDA)","company":"Various","advantage":"Lower price and increased availability"},{"name":"Pharmacokinetic (PK) BE Study","company":"Various","advantage":"Allows for assessment of absorption and differentiation between formulations"},{"name":"2-way Single Dose Crossover Design","company":"Various","advantage":"Allows for assessment of absorption and differentiation between formulations"},{"name":"Parallel Design","company":"Various","advantage":"Allows for comparison of two treatments"},{"name":"Replicate Design","company":"Various","advantage":"Allows for comparison of multiple treatments"},{"name":"Fasting Study","company":"Various","advantage":"Allows for assessment of drug absorption in a fasting state"},{"name":"Non-fasting (a.k.a. Fed) Study","company":"Various","advantage":"Allows for assessment of drug absorption in a non-fasting state"},{"name":"Sprinkled-fasting (or fed) Study","company":"Various","advantage":"Allows for assessment of drug absorption in a sprinkled-fasting state"},{"name":"Dissolution Testing","company":"Various","advantage":"Allows for comparison of dissolution profiles between test and reference products"},{"name":"Bio-waiver","company":"Various","advantage":"Allows for waiver of bioequivalence studies for certain drug products"},{"name":"BCS (Biopharmaceutics Classification System) drugs","company":"Various","advantage":"Allows for classification of drugs based on their solubility and permeability"}],"genericName":"test-formulation-treatment-a","indications":{"approved":[{"name":"Acute Bacterial Sinusitis","regulator":"FDA"},{"name":"Acute Bacterial Exacerbation of Chronic Bronchitis","regulator":"FDA"},{"name":"Community-Acquired Pneumonia","regulator":"FDA"},{"name":"Pharyngitis/tonsillitis","regulator":"FDA"},{"name":"Skin and Skin Structure Infections","regulator":"FDA"},{"name":"Complicated Urinary Tract Infections","regulator":"FDA"},{"name":"Uncomplicated Urinary Tract Infections","regulator":"FDA"},{"name":"Acute Bacterial Otitis Media","regulator":"FDA"},{"name":"Pyelonephritis","regulator":"FDA"},{"name":"Influenza","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Hospitalized Adults","regulator":"FDA"},{"name":"Acute Bacterial Exacerbation of Chronic Obstructive Pulmonary Disease","regulator":"FDA"},{"name":"Uncomplicated Skin and Skin Structure Infections","regulator":"FDA"},{"name":"Community-Acquired Bacterial Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"},{"name":"Community-Acquired Pneumonia in Adults","regulator":"FDA"}],"offLabel":[],"pipeline":["Condition X","Condition Y"]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07497087","phase":"PHASE3","title":"A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-06-09","conditions":"Systemic Sclerosis","enrollment":448},{"nctId":"NCT06948084","phase":"PHASE2","title":"Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-29","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":80},{"nctId":"NCT07498387","phase":"NA","title":"Management of Catatonic Features in Adolescents With Profound Autism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Autism Spectrum Disorder, Catatonia","enrollment":30},{"nctId":"NCT06290141","phase":"PHASE3","title":"A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-08-21","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":160},{"nctId":"NCT07388524","phase":"PHASE3","title":"Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-09","conditions":"Lung Non-Small Cell Carcinoma","enrollment":336},{"nctId":"NCT04310007","phase":"PHASE2","title":"Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-13","conditions":"Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":117},{"nctId":"NCT07492771","phase":"PHASE1","title":"MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"MicrobiotiX Co., Ltd","startDate":"2026-03","conditions":"Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection","enrollment":18},{"nctId":"NCT07250048","phase":"PHASE1","title":"A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-11-21","conditions":"Healthy","enrollment":40},{"nctId":"NCT07486453","phase":"PHASE1","title":"Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2026-03-09","conditions":"Primary Hypertension","enrollment":60},{"nctId":"NCT05422794","phase":"PHASE1","title":"Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-18","conditions":"Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast Carcinoma","enrollment":57},{"nctId":"NCT07251712","phase":"PHASE1","title":"Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet","status":"RECRUITING","sponsor":"Galmed Pharmaceuticals Ltd","startDate":"2025-12-25","conditions":"Healthy","enrollment":32},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Meibomian Gland Dysfunction (MGD)","enrollment":48},{"nctId":"NCT07221591","phase":"PHASE1","title":"A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-11-05","conditions":"Healthy","enrollment":100},{"nctId":"NCT07071974","phase":"PHASE1","title":"A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-07-28","conditions":"Healthy","enrollment":16},{"nctId":"NCT07433569","phase":"PHASE1","title":"A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-03-05","conditions":"Asthma","enrollment":12},{"nctId":"NCT06626633","phase":"PHASE1","title":"2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML","status":"SUSPENDED","sponsor":"University of Maryland, Baltimore","startDate":"2024-08-26","conditions":"Acute Myeloid Leukemia","enrollment":6},{"nctId":"NCT07463001","phase":"NA","title":"Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Municipalities","status":"NOT_YET_RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2026-03-23","conditions":"School Attendance Problems","enrollment":240},{"nctId":"NCT07413913","phase":"PHASE1","title":"A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-03-03","conditions":"Healthy, Obesity","enrollment":56},{"nctId":"NCT04566328","phase":"PHASE3","title":"Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-02-24","conditions":"Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma","enrollment":1450},{"nctId":"NCT07268625","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-12-09","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT07261371","phase":"PHASE1","title":"A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-11-24","conditions":"Healthy Volunteer","enrollment":64},{"nctId":"NCT05755932","phase":"PHASE3","title":"Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-06-14","conditions":"Mucociliary Clearance","enrollment":35},{"nctId":"NCT02264678","phase":"PHASE1, PHASE2","title":"Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2014-10-31","conditions":"Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer","enrollment":357},{"nctId":"NCT05396833","phase":"PHASE1","title":"Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)","status":"ACTIVE_NOT_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2022-06-07","conditions":"Metastatic or Locally Advanced Unresectable Solid Tumors","enrollment":120},{"nctId":"NCT07419672","phase":"NA","title":"Intra Oral Application (IOA) Testing Study of a Stannous Toothpaste","status":"COMPLETED","sponsor":"Church & Dwight Company, Inc.","startDate":"2024-08-12","conditions":"Dental Caries","enrollment":31},{"nctId":"NCT06125951","phase":"PHASE2, PHASE3","title":"Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actinogen Medical","startDate":"2024-04-12","conditions":"Dementia Moderate, Dementia, Mild, Alzheimer Disease","enrollment":247},{"nctId":"NCT07286487","phase":"NA","title":"Glycyrrhetinic Acid and Acute Irritant Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"University of Split, School of Medicine","startDate":"2026-03-01","conditions":"Irritant Contact Dermatitis","enrollment":30},{"nctId":"NCT06685809","phase":"PHASE1","title":"A Phase 1 Study of FZ008-145 in Healthy Subjects.","status":"RECRUITING","sponsor":"Guangzhou Fermion Technology Co., LTD","startDate":"2024-11-25","conditions":"Healthy","enrollment":190},{"nctId":"NCT07343973","phase":"NA","title":"Post-Market Study on the Safety and Effectiveness of the OpHLINE OVD in Cataract Surgery","status":"COMPLETED","sponsor":"i+Med S.Coop.","startDate":"2021-03-02","conditions":"Cataract Surgery","enrollment":69},{"nctId":"NCT06911567","phase":"PHASE1","title":"A Study to Assess New Formulations of TEV-56286","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D LLC","startDate":"2025-03-10","conditions":"Healthy Participants","enrollment":47},{"nctId":"NCT05850494","phase":"PHASE3","title":"Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-05-02","conditions":"Asthma","enrollment":52},{"nctId":"NCT07079930","phase":"PHASE1","title":"Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2025-12-11","conditions":"Healthy Volunteers","enrollment":10},{"nctId":"NCT07235189","phase":"PHASE1","title":"A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-10-28","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT06958328","phase":"PHASE3","title":"Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2025-08-21","conditions":"Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8","enrollment":356},{"nctId":"NCT07370051","phase":"NA","title":"Effect of Topical Oxygen and LED Light Therapy on Nipple Crack","status":"NOT_YET_RECRUITING","sponsor":"Istanbul University - Cerrahpasa","startDate":"2026-03-15","conditions":"Breastfeeding, Newborn Infant, Midwifery","enrollment":51},{"nctId":"NCT06930157","phase":"PHASE4","title":"Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2025-11-24","conditions":"Low-risk Colorectal Adenoma","enrollment":624},{"nctId":"NCT07360639","phase":"PHASE1, PHASE2","title":"The Effectiveness of Herbal Creams Compared to Urea in Dry Skin Treatment","status":"COMPLETED","sponsor":"Universitas Syiah Kuala","startDate":"2025-06-01","conditions":"Dry Skin, Xerosis Cutis","enrollment":64},{"nctId":"NCT05028062","phase":"PHASE4","title":"Naltrexone in AUD Reward Drinkers","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-03-07","conditions":"Alcohol Use Disorder, Alcoholism","enrollment":60},{"nctId":"NCT07347340","phase":"PHASE3","title":"Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-01-01","conditions":"Diminished Ovarian Reserve (DOR)","enrollment":348},{"nctId":"NCT06676007","phase":"","title":"A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2024-10-30","conditions":"IgA Nephropathy (IgAN), Early Initial Therapy","enrollment":200},{"nctId":"NCT07220551","phase":"PHASE1","title":"A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2025-10-23","conditions":"Healthy Volunteers","enrollment":14},{"nctId":"NCT07316608","phase":"PHASE1","title":"A Phase I, Open-label, Crossover Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-03-16","conditions":"Healthy Participants","enrollment":44},{"nctId":"NCT07050485","phase":"NA","title":"Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of South Florida","startDate":"2025-07-15","conditions":"Colon Cancer, Gastrointestinal Cancer","enrollment":30},{"nctId":"NCT06291285","phase":"PHASE1","title":"A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy People","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-02-27","conditions":"Healthy Volunteers","enrollment":44},{"nctId":"NCT06397144","phase":"PHASE1","title":"A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2025-08-15","conditions":"Biological Availability, Healthy Participants","enrollment":0},{"nctId":"NCT05428436","phase":"PHASE1","title":"A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2022-08-15","conditions":"Healthy","enrollment":24},{"nctId":"NCT07201545","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-10-07","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT07182383","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-09-29","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT07268430","phase":"NA","title":"Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia","status":"COMPLETED","sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","startDate":"2023-12-18","conditions":"Schizophrenia","enrollment":256},{"nctId":"NCT06408870","phase":"PHASE1","title":"A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-06-06","conditions":"Healthy","enrollment":64},{"nctId":"NCT06415045","phase":"PHASE1","title":"A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-05-28","conditions":"Healthy","enrollment":18},{"nctId":"NCT06393127","phase":"PHASE1","title":"A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-06-04","conditions":"Healthy","enrollment":64},{"nctId":"NCT07136181","phase":"PHASE1, PHASE2","title":"Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma","status":"RECRUITING","sponsor":"Novelwise Pharmaceutical Corporation","startDate":"2025-11-20","conditions":"Metastatic Uveal Melanoma, Uveal Melanoma, Metastatic, Uveal Melanoma, Recurrent","enrollment":36},{"nctId":"NCT07130097","phase":"PHASE1","title":"A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants","status":"COMPLETED","sponsor":"Pfizer","startDate":"2025-08-14","conditions":"Healthy Participant","enrollment":35},{"nctId":"NCT06411522","phase":"NA","title":"Clinical and Microbiological Comparison of 0.12% CHX and 0.05% CHX+0.05%CPC Mouthwashes in TPS Patients","status":"COMPLETED","sponsor":"University of Siena","startDate":"2024-05-20","conditions":"Chlorhexidine, Gingivitis, Periodontitis","enrollment":72},{"nctId":"NCT07008417","phase":"PHASE1","title":"A Study on Bioequivalence of Cabergoline Tablets in Human Body","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-06-30","conditions":"Hyperprolactinemia","enrollment":72},{"nctId":"NCT05380947","phase":"PHASE1","title":"A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2022-06-23","conditions":"Healthy","enrollment":13},{"nctId":"NCT07222878","phase":"PHASE1","title":"Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042","status":"RECRUITING","sponsor":"NeuroPro Therapeutics, Inc.","startDate":"2025-09-29","conditions":"Epilepsy, Alzheimer Disease, Epilepsy Intractable","enrollment":8},{"nctId":"NCT05662033","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-12-05","conditions":"Inflammatory Diseases","enrollment":93},{"nctId":"NCT07220915","phase":"PHASE3","title":"Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections","status":"NOT_YET_RECRUITING","sponsor":"Octapharma","startDate":"2025-12","conditions":"Hypogammaglobulinemia, Autoimmune Conditions, Rheumatic Conditions","enrollment":360},{"nctId":"NCT06331156","phase":"PHASE3","title":"A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-03-22","conditions":"Gastroenteritis","enrollment":400},{"nctId":"NCT07122973","phase":"NA","title":"Topographical Distribution of Itch and Pain Receptors","status":"RECRUITING","sponsor":"Aalborg University","startDate":"2025-09-17","conditions":"Pain, Itch","enrollment":30},{"nctId":"NCT06299709","phase":"PHASE1","title":"A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-03-13","conditions":"Cystic Fibrosis","enrollment":34},{"nctId":"NCT06191965","phase":"PHASE2, PHASE3","title":"MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-06-01","conditions":"Schizophrenia and Related Disorders, Mitochondrial Alteration, Cognitive Impairment","enrollment":100},{"nctId":"NCT05425056","phase":"PHASE3","title":"A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery","status":"COMPLETED","sponsor":"Vascular Therapies, Inc.","startDate":"2022-08-26","conditions":"Complication of Renal Dialysis, End Stage Renal Disease, End Stage Kidney Disease","enrollment":136},{"nctId":"NCT06572111","phase":"PHASE1","title":"A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2024-09-30","conditions":"Healthy","enrollment":8},{"nctId":"NCT04714073","phase":"PHASE1","title":"A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-02-11","conditions":"Healthy","enrollment":14},{"nctId":"NCT05477108","phase":"PHASE1","title":"Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-07-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":108},{"nctId":"NCT06650644","phase":"NA","title":"A Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder for Improving Autism Spectrum Symptoms in Children With Autism Spectrum Symptoms.","status":"COMPLETED","sponsor":"Miae Oh","startDate":"2024-10-10","conditions":"Autism Spectrum Disorder","enrollment":48},{"nctId":"NCT07138014","phase":"PHASE2","title":"FHND1002 for ALS Treatment: Phase 2","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","startDate":"2025-10-01","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":180},{"nctId":"NCT05569421","phase":"PHASE1","title":"A Study to Assess the Total Systemic Exposure Bioequivalence of of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-10-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":108},{"nctId":"NCT05782361","phase":"PHASE1","title":"POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2023-05-03","conditions":"Advanced Cancer, Non Small Cell Lung Cancer","enrollment":19},{"nctId":"NCT06297668","phase":"PHASE1","title":"A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-Generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-04-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":42},{"nctId":"NCT06631417","phase":"PHASE1","title":"A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-10-22","conditions":"Healthy","enrollment":30},{"nctId":"NCT06702449","phase":"PHASE1, PHASE2","title":"A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-11-19","conditions":"Urinary Tract Infections","enrollment":448},{"nctId":"NCT06904235","phase":"PHASE2","title":"Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)","status":"RECRUITING","sponsor":"Helsinn Healthcare SA","startDate":"2025-07-07","conditions":"Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy","enrollment":95},{"nctId":"NCT02568826","phase":"PHASE2","title":"Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain","status":"WITHDRAWN","sponsor":"Indena S.p.A","startDate":"2016-04","conditions":"Low Back Pain","enrollment":0},{"nctId":"NCT06955754","phase":"PHASE1","title":"A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-05-20","conditions":"Healthy","enrollment":16},{"nctId":"NCT07072806","phase":"PHASE4","title":"A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2022-06-14","conditions":"Forehead Rhytides","enrollment":20},{"nctId":"NCT06911788","phase":"PHASE1","title":"A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up Into the Blood in Healthy Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2025-04-03","conditions":"Healthy Participants","enrollment":10},{"nctId":"NCT06309719","phase":"NA","title":"Hyaluronic Acid and Polynucleotides for Supra-bony Defects","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-10-21","conditions":"Periodontal Diseases, Wound Heal, Periodontal Inflammation","enrollment":24},{"nctId":"NCT06723756","phase":"PHASE1","title":"A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-01-23","conditions":"Healthy Participants","enrollment":105},{"nctId":"NCT06969495","phase":"NA","title":"Pilot Clinical Study Testing Tiger Milk Mushroom Gel (Lignosus Rhinocerus TM02®) for Treating Mouth Ulcers","status":"COMPLETED","sponsor":"Mahsa University","startDate":"2023-02-01","conditions":"Mouth Ulcer","enrollment":21},{"nctId":"NCT06841926","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males","status":"COMPLETED","sponsor":"Nanjing Zenshine Pharmaceuticals","startDate":"2025-02-20","conditions":"Respiratory Viral Infection","enrollment":40},{"nctId":"NCT06948461","phase":"PHASE2","title":"A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.","status":"NOT_YET_RECRUITING","sponsor":"PharmaPlanter Technologies Inc","startDate":"2025-09-01","conditions":"Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D), Recurrent Clostridioides Difficile Infection (rCDI), Fecal Microbiota Therapy (FMT)","enrollment":63},{"nctId":"NCT03682380","phase":"PHASE1","title":"A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-10-01","conditions":"Healthy","enrollment":151},{"nctId":"NCT04553042","phase":"PHASE1","title":"A Study of Seltorexant in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-14","conditions":"Healthy","enrollment":69},{"nctId":"NCT04468360","phase":"PHASE2","title":"Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD","status":"RECRUITING","sponsor":"Boston University","startDate":"2022-03-04","conditions":"Post Traumatic Stress Disorder","enrollment":256},{"nctId":"NCT06486558","phase":"PHASE1","title":"Relative Bioavailability Study of HU6","status":"COMPLETED","sponsor":"Rivus Pharmaceuticals, Inc.","startDate":"2024-07-24","conditions":"Healthy","enrollment":43},{"nctId":"NCT06812221","phase":"PHASE1, PHASE2","title":"Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI","status":"COMPLETED","sponsor":"Biomind Labs Inc.","startDate":"2024-12-15","conditions":"Mild Cognitive Impairment, Anxiety State, Depression Anxiety Disorder","enrollment":20},{"nctId":"NCT05627518","phase":"PHASE1","title":"Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation","status":"COMPLETED","sponsor":"Cinclus Pharma Holding AB","startDate":"2022-11-15","conditions":"Safety, Bioavailability, Pharmacokinetics","enrollment":67},{"nctId":"NCT06891924","phase":"NA","title":"A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine","status":"NOT_YET_RECRUITING","sponsor":"Botanee Group Co., Ltd.","startDate":"2025-03-25","conditions":"Skin Aging, Skin Condition, Skin Manifestations","enrollment":33},{"nctId":"NCT04963439","phase":"PHASE1","title":"A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants","status":"COMPLETED","sponsor":"Actelion","startDate":"2021-07-08","conditions":"Healthy","enrollment":16},{"nctId":"NCT05392530","phase":"PHASE1","title":"A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult Participants","status":"COMPLETED","sponsor":"Actelion","startDate":"2022-05-25","conditions":"Healthy","enrollment":23},{"nctId":"NCT04235270","phase":"PHASE1","title":"A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-01-17","conditions":"Healthy","enrollment":62},{"nctId":"NCT04540744","phase":"PHASE1","title":"A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-04-30","conditions":"Healthy","enrollment":18},{"nctId":"NCT05236231","phase":"PHASE1","title":"A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participants","status":"COMPLETED","sponsor":"Actelion","startDate":"2022-02-04","conditions":"Healthy","enrollment":40},{"nctId":"NCT06890507","phase":"PHASE2","title":"The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)","status":"NOT_YET_RECRUITING","sponsor":"University of Adelaide","startDate":"2025-06-01","conditions":"Angina Attacks, Non Obstructive Coronary Artery Disease","enrollment":25},{"nctId":"NCT06566430","phase":"NA","title":"PrEP My Way: a Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-03-03","conditions":"HIV/AIDS","enrollment":500},{"nctId":"NCT06252506","phase":"PHASE1","title":"Molecular Imaging Study of Harmine/DMT: a Basic Research Approach","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-01-22","conditions":"Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine","enrollment":17}],"_emaApprovals":[{"date":"","name":"Test formulation (Treatment A)","status":"Authorised","regulator":"EMA"}],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL2108771","moleculeType":"Unknown","molecularWeight":""},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL2108771"},"formularyStatus":[],"_approvalHistory":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"Not yet determined","enrichmentLevel":3,"visitCount":4,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:53:54.921812+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}